Company intelligence / Profile preview
Kotra Pharma
- Ownership
- Private
- Development stage
- Commercial
Overview
Kotra Pharma has a broad commercial portfolio with multiple brands covering oral/topical preparations for paediatrics and dermatology; sterile injectables for anti-infectives and anaesthesia; respiratory devices; pain relief products; and health supplements. The company focuses on quality manufacturing standards including PIC/S GMP compliance and Halal certification. No clinical trial results are publicly highlighted.
- Therapeutic areas
- PulmonologyOtherDermatologyGastroenterologyCardiovascularInfectious Diseases
- Modalities
- Small moleculeHealth supplement (nutraceutical)Device (respiratory devices)Topical preparation (creams/ointments)Sterile injectable pharmaceutical products
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Beyond the preview
Go deeper on Kotra Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kotra Pharma.